These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23300273)

  • 21. Uptake of nicotinic acetylcholine receptor imaging agent is reduced in the pro-inflammatory macrophage.
    Suzuki M; Katayama T; Suzuki C; Nakajima K; Magata Y; Ogawa M
    Nucl Med Biol; 2021; 102-103():45-55. PubMed ID: 34619460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
    Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes.
    Katsuki S; Matoba T; Nakashiro S; Sato K; Koga J; Nakano K; Nakano Y; Egusa S; Sunagawa K; Egashira K
    Circulation; 2014 Feb; 129(8):896-906. PubMed ID: 24305567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice.
    Li X; Bauer W; Kreissl MC; Weirather J; Bauer E; Israel I; Richter D; Riehl G; Buck A; Samnick S
    Atherosclerosis; 2013 Sep; 230(1):33-9. PubMed ID: 23958249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
    Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Imaging of Matrix Metalloproteinase-2 in Atherosclerosis Using a Smart Multifunctional PET/MRI Nanoparticle.
    Tu Y; Ma X; Chen H; Fan Y; Jiang L; Zhang R; Cheng Z
    Int J Nanomedicine; 2022; 17():6773-6789. PubMed ID: 36600879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
    Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo MRI detection of carotid atherosclerotic lesions and kidney inflammation in ApoE-deficient mice by using LOX-1 targeted iron nanoparticles.
    Wen S; Liu DF; Cui Y; Harris SS; Chen YC; Li KC; Ju SH; Teng GJ
    Nanomedicine; 2014 Apr; 10(3):639-49. PubMed ID: 24103305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin.
    Liu Z; Larsen BT; Lerman LO; Gray BD; Barber C; Hedayat AF; Zhao M; Furenlid LR; Pak KY; Woolfenden JM
    Nucl Med Biol; 2016 Aug; 43(8):496-505. PubMed ID: 27236285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.
    Nahrendorf M; Keliher E; Panizzi P; Zhang H; Hembrador S; Figueiredo JL; Aikawa E; Kelly K; Libby P; Weissleder R
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1213-22. PubMed ID: 19833312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical evaluation of an
    Park JY; Kim HJ; Chae JR; Cho YL; Kang WJ
    Biochem Biophys Res Commun; 2024 Apr; 703():149650. PubMed ID: 38377941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM.
    Nie X; Randolph GJ; Elvington A; Bandara N; Zheleznyak A; Gropler RJ; Woodard PK; Lapi SE
    Nucl Med Biol; 2016 Sep; 43(9):534-542. PubMed ID: 27372286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CC Chemokine Receptor 5 Targeted Nanoparticles Imaging the Progression and Regression of Atherosclerosis Using Positron Emission Tomography/Computed Tomography.
    Detering L; Abdilla A; Luehmann HP; Williams JW; Huang LH; Sultan D; Elvington A; Heo GS; Woodard PK; Gropler RJ; Randolph GJ; Hawker CJ; Liu Y
    Mol Pharm; 2021 Mar; 18(3):1386-1396. PubMed ID: 33591187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles.
    Pérez-Medina C; Tang J; Abdel-Atti D; Hogstad B; Merad M; Fisher EA; Fayad ZA; Lewis JS; Mulder WJ; Reiner T
    J Nucl Med; 2015 Aug; 56(8):1272-7. PubMed ID: 26112022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions.
    Segers FM; den Adel B; Bot I; van der Graaf LM; van der Veer EP; Gonzalez W; Raynal I; de Winther M; Wodzig WK; Poelmann RE; van Berkel TJ; van der Weerd L; Biessen EA
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1812-9. PubMed ID: 23744990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques.
    van Tilborg GA; Vucic E; Strijkers GJ; Cormode DP; Mani V; Skajaa T; Reutelingsperger CP; Fayad ZA; Mulder WJ; Nicolay K
    Bioconjug Chem; 2010 Oct; 21(10):1794-803. PubMed ID: 20804153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage uptake switches on OCT contrast of superparamagnetic nanoparticles for imaging of atherosclerotic plaques.
    Ariza de Schellenberger A; Poller WC; Stangl V; Landmesser U; Schellenberger E
    Int J Nanomedicine; 2018; 13():7905-7913. PubMed ID: 30538467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor-targeted iron oxide nanoparticles for molecular MR imaging of inflamed atherosclerotic plaques.
    Tu C; Ng TS; Sohi HK; Palko HA; House A; Jacobs RE; Louie AY
    Biomaterials; 2011 Oct; 32(29):7209-16. PubMed ID: 21742374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.